Clinical Trial: Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Anti-tumor Necrosis Factor Therapy Effect on Takayasu Arteritis
Brief Summary:
Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.
This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11
Detailed Summary:
Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.
This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11 patients with active takayasu's arteritis
Sponsor: Seoul National University Hospital
Current Primary Outcome: remission induction at 30 weeks [ Time Frame: 30 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Seoul National University Hospital
Dates:
Date Received: May 18, 2015
Date Started: March 2015
Date Completion: April 2018
Last Updated: May 12, 2017
Last Verified: March 2017